Navigation Links
Watson Pharmaceuticals to Webcast Annual Meeting of Stockholders on May 13th
Date:4/29/2011

PARSIPPANY, N.J., April 29, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), an integrated global specialty pharmaceutical company, announced today that the Company will conduct a live webcast of its 2011 Annual Meeting of Stockholders on Friday May 13, 2011 beginning at 9:00 AM Eastern Daylight Time. As part of the meeting, Paul Bisaro, Watson's president and chief executive officer, will provide an overview and update of the Company's business.

The webcast can be accessed on Watson Pharmaceuticals' Investor Relations Website or directly at http://www.videonewswire.com/event.asp?id=78629. An archived version of the webcast will be available for 30 days beginning several hours after the live presentation concludes.

About Watson Pharmaceuticals, Inc.Watson Pharmaceuticals, Inc. is an integrated global specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health. Watson has operations in many of the world's established and growing international markets.

For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com/.

(Logo:  http://photos.prnewswire.com/prnh/20100121/LA41294LOGO)CONTACTS:Investors:Patty Eisenhaur(862) 261-8141Media:Charlie Mayr(862) 261-8030
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Watson First Quarter 2011 Net Revenue Increases to $877 Million
2. New Life Agency Adds Watson to Join Walgreens on The Fertility Pharmacy Care Card for Fertility Medication
3. Watson Confirms Welchol® Patent Challenge
4. Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results
5. Watson to Host Conference Call and Webcast to Discuss First Quarter 2011 Earnings
6. Watson Announces Approval of Nulecit™, the First Generic Alternative to Ferrlecit® for the Treatment of Iron Deficiency Anemia
7. Watson Confirms Favorable Appeals Court Ruling on Generic SEASONIQUE® Patent Challenge
8. Watson Confirms OxyContin® Patent Challenge
9. Watson Confirms District Court Ruling in Generic Fentora® Patent Suit
10. Cephalon Wins FENTORA Patent Suit Against Watson
11. Watson Launches Generic Famvir®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/2/2017)... -- CaryRx, a next-generation full-service pharmacy, has announced the launch ... the Washington D.C. metropolitan area. CaryRx ... of medications through the convenience of its patient-friendly mobile app. ... one hour to any location in D.C. ... service to Washington D.C. ," says Areo ...
(Date:7/31/2017)... July 31, 2017 7D Surgical, developer of ground ... purchased the 7D Surgical System to support its strategic sales ... D.C. and Virginia.  7D Surgical has entered into ... of the premier medical facilities within those markets. ... ...
(Date:7/27/2017)... Pharmaceutical Services, Inc. (NYSE: WST ) today ... updated financial guidance for the full-year 2017. ... Reported net sales of $397.6 million, a record ... at constant currency (organic) grew by 3.9%. ... $0.60 in the prior-year quarter. Second-quarter 2017 adjusted diluted ...
Breaking Medicine Technology:
(Date:8/16/2017)... ... August 16, 2017 , ... Greenfield Advisors is honored to be ... for the second year in a row. The Inc. 5000 list honors private businesses ... “To be on the list once is a great accomplishment, but for us to ...
(Date:8/16/2017)... ... August 16, 2017 , ... In 1987, McDaniel & Durrett, ... in business this year, and they’re marking the milestone by undertaking a significant ... patients. , It stands to reason that, given the central importance of ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... has received a three-year grant totaling $975,000, renewing its funding from the Health ... Human Services. , This funding marks, the fourth time the HRSA administration has ...
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... ... Endoscopes states: “Drying the endoscope after every reprocessing cycle, both between patient procedures ... transmission and nosocomial infections. Drying is as important to the prevention of disease ...
(Date:8/16/2017)... Lake City, Utah (PRWEB) , ... August 16, 2017 , ... ... spot on the Inc 5000 list for the fourth consecutive year. With ... Inc. 5000 2017 list of the nation’s fastest growing companies. , Previous ...
Breaking Medicine News(10 mins):